BOSTON — June 15, 2015 —David J. Dykeman, David C. Peck, and Timothy D. Johnston, attorneys with international law firm Greenberg Traurig, LLP, will speak at the DeviceTalks Boston, June 17, 2015 at Boston Scientific’s Global Headquarters, Marlborough, Massachusetts.
From 4 - 5:30 p.m., Dykeman, Boston shareholder and co-chair of the firm’s global Life Sciences & Medical Technology Group, will moderate the panel discussion, “Hot Topics: M&A Megadeals, IP, Financing, and Products Liability Trends for MedTech Companies.” Peck, Fort Lauderdale shareholder and co-chair of the firm’s global Life Sciences & Medical Technology Group, and Johnston, Boston attorney in the firm’s Pharmaceutical, Medical Device & Health Care Litigation Group, will serve as panelists. They will be joined by medtech leaders: Charlie Attlan, vice president, Head of Corporate Business Development and Portfolio, Boston Scientific; Jed Cohen, managing director, Leerink Partners; and Jeff Mann, senior managing counsel, Med-Surg at Boston Scientific.
Hosted by online journal MassDevice.com, DeviceTalks is a conversation among leaders. It’s an evening for an exchange of ideas, insight, and contacts among the pioneers of the medical technology industry. Formerly known as the Big 100, this event is held annually in Boston, Orange County, and the Twin Cities.